TradingNote
Gurus
Top InvestorsCongress TradesInsider Trades

Top Investors

Warren BuffettCathie WoodLi LuRay DalioBill AckmanView all Top Investors
Archive
Industry
AI & ComputeSoftware & DigitalHealthcare InnovationFinancial InfrastructureEnergy & GridIndustrial AutomationConsumer & CommerceReal Estate & AssetsMaterials & ManufacturingListed Vehicles

AI & Compute

Semiconductors & AcceleratorsCloud & AI PlatformsData Center & NetworkingView all AI & Compute
ResearchApp

AKYA

Akoya Biosciences, Inc.

Investor Moves

NameValueActionChangePriceCurrent Price
Ken GriffinCitadel Advisors
$-130.6K
ExitQ3 2025
$131k
--
$1.29
Ken GriffinCitadel Advisors
$104.3K
AddQ2 2025
$104k
--
$1.29
Ken GriffinCitadel Advisors
$-63.1K
TrimQ1 2025
$63k
--
$1.29
Ken GriffinCitadel Advisors
$-117.0K
TrimQ4 2024
$117k
--
$1.29
Trade AKYA

About Akoya Biosciences, Inc.

Akoya Biosciences, Inc. is a prominent life sciences technology firm dedicated to furnishing advanced spatial biology solutions. The company's mission is to significantly advance both discovery and clinical research across numerous global regions, including North America, Asia Pacific, Europe, the Middle East, and Africa. Their core product lineup features the PhenoCycler instrument, a compact benchtop fluidics system designed to integrate seamlessly with a microscope for automated image acquisition. Complementing this is the PhenoImager platform, which empowers researchers to intricately visualize, analyze, quantify, and characterize cells directly within diverse tissue samples—such as fresh frozen or FFPE sections and tissue microarrays—through an efficient, automated, and high-throughput process. Akoya also supplies the essential reagents for these PhenoCycler and PhenoImager systems, alongside providing specialized biopharmaceutical services. Beyond hardware, Akoya offers a robust suite of software tools. Proxima serves as a cloud-based platform for the secure storage, comprehensive analysis, and collaborative sharing of spatial data. For image interpretation, the inForm Tissue software delivers automated analysis to precisely visualize and quantify biomarkers within tissue sections. Further streamlining data workflows, Phenoptr facilitates the consolidation and in-depth analysis of output tables generated by inForm. Finally, phenoptrReports is a user-friendly software application that generates intuitive reports and visualizations from phenoptr output, presented via an easy-to-navigate graphical user interface. Established in 2015, Akoya Biosciences maintains its corporate headquarters in Marlborough, Massachusetts.

CEO
Brian McKelligon
IPO Date
Apr 16, 2021

Market Data

OpenThe first traded price for the current trading session.
$1.29
HighThe highest traded price in the current trading session.
$1.29
LowThe lowest traded price in the current trading session.
$1.29
VolumeTotal shares traded during the current trading session.
715.3K
Avg VolumeAverage number of shares traded per session, as reported by FMP.
582.1K
52W HighThe highest traded price over the past 52 weeks.
$3.42
52W LowThe lowest traded price over the past 52 weeks.
$0.931

Valuation

Market CapCompany equity value based on share price multiplied by shares outstanding.
$64.4M
Enterprise ValueMarket cap plus debt and other claims, less cash and equivalents.
$127.8M
Dividend YieldAnnualized dividend yield relative to the current share price.
0.00%

Financials

Free Cash FlowOperating cash flow minus capital expenditures from the latest annual cash flow statement.
-$46.6M
RevenueTotal sales from the latest annual income statement.
$81.7M
Net IncomeProfit after expenses and taxes from the latest annual income statement.
-$55.4M
CashCash and equivalents, or cash plus short-term investments, from the latest balance sheet.
$11.8M
DebtTotal debt from the latest balance sheet.
$84.1M

Events

EarningsAug 4

EPS est. -0.22 · actual -0.27

Top Market Industries

AI & Compute
  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking
Software & Digital
  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media
Healthcare
  • GLP-1 & Metabolic Health
  • Biotech & Oncology
  • Medical Devices & Diagnostics
  • Healthcare Services
  • Pharmaceuticals
Financial Infrastructure
  • Banks & Capital Markets
  • Asset Management & Exchanges
  • Insurance
  • Payments & Fintech
  • Digital Assets
Energy & Grid
  • Oil, Gas & Fuels
  • Nuclear & Grid Power
  • Renewables & Storage
  • Utilities
  • Energy Services
Industrial Automation & Defense
  • Aerospace & Defense
  • Robotics & Automation
  • Machinery & Equipment
  • Logistics & Transportation
  • Construction & Infrastructure
Consumer & Commerce
  • Retail & E-commerce
  • Restaurants & Food Service
  • Consumer Brands
  • Autos & Mobility
  • Travel & Leisure
Real Estate & Physical Assets
  • REITs
  • Real Estate Services
  • Housing & Building Products

AI & Compute

  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking

Software & Digital

  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media

Healthcare

  • GLP-1 & Metabolic Health
  • Biotech & Oncology
  • Medical Devices & Diagnostics
  • Healthcare Services
  • Pharmaceuticals

Financial Infrastructure

  • Banks & Capital Markets
  • Asset Management & Exchanges
  • Insurance
  • Payments & Fintech
  • Digital Assets

Energy & Grid

  • Oil, Gas & Fuels
  • Nuclear & Grid Power
  • Renewables & Storage
  • Utilities
  • Energy Services

Industrial Automation & Defense

  • Aerospace & Defense
  • Robotics & Automation
  • Machinery & Equipment
  • Logistics & Transportation
  • Construction & Infrastructure

Consumer & Commerce

  • Retail & E-commerce
  • Restaurants & Food Service
  • Consumer Brands
  • Autos & Mobility
  • Travel & Leisure

Real Estate & Physical Assets

  • REITs
  • Real Estate Services
  • Housing & Building Products
Trending Industries
  • AI & Compute Infrastructure
  • Software & Digital Platforms
  • Healthcare Innovation
  • Financial Infrastructure
  • Energy & Grid
  • Industrial Automation & Defense
  • Consumer & Commerce
  • Real Estate & Physical Assets
Top Investors
  • Warren Buffett
  • Cathie Wood
  • Li Lu
  • Ray Dalio
  • Bill Ackman
  • Duan Yongping
  • Michael Burry
  • Ken Griffin
Trending Stocks
  • NEE
  • NVDA
  • LLY
  • MSFT
  • AAPL
  • META
  • AMD
  • AMZN
Browse
  • App
  • Archive
  • Industries
  • Categories
  • Investors
  • Methodology
  • Watchlist

Trending Industries

  • AI & Compute Infrastructure
  • Software & Digital Platforms
  • Healthcare Innovation
  • Financial Infrastructure
  • Energy & Grid
  • Industrial Automation & Defense
  • Consumer & Commerce
  • Real Estate & Physical Assets

Top Investors

  • Warren Buffett
  • Cathie Wood
  • Li Lu
  • Ray Dalio
  • Bill Ackman
  • Duan Yongping
  • Michael Burry
  • Ken Griffin

Trending Stocks

  • NEE
  • NVDA
  • LLY
  • MSFT
  • AAPL
  • META
  • AMD
  • AMZN

Browse

  • App
  • Archive
  • Industries
  • Categories
  • Investors
  • Methodology
  • Watchlist
© 2026 TradingNote
AppArchiveIndustriesCategoriesInvestorsMethodologyWatchlistPrivacyTerms